Search results for "cholinesterase"

showing 10 items of 148 documents

Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD).

2009

Acetylcholinesterase inhibitors (AchEIs) are extensively used in Alzheimer's disease (AD) while reality orientation therapy (ROT) is a cognitive rehabilitation indicated for mentally deteriorated patients. We aimed to evaluate the efficacy of the combination of donepezil with an intensive ROT with active participation of the caregiver. Patients with AD (n=100, mean age 78.4±4.3 years) initiated treatment with donepezil, 5mg/day; 62 of them underwent a 3-week, daily ROT and physical reactivation training with the caregiver (Group A); 38 participants received only donepezil therapy (Group B). All subjects were tested for cognitive and functional abilities at baseline, at the end of the traini…

MaleAgingmedicine.medical_specialtyHealth (social science)Diseasechemistry.chemical_compoundPiperidinesAlzheimer Diseasemental disordersmedicineDementiaHumansDonepezilCognitive rehabilitation therapyDonepezilAgedAged 80 and overPsychiatric Status Rating ScalesAnalysis of VarianceChi-Square DistributionCognitive Behavioral TherapyCognitionmedicine.diseaseAcetylcholinesteraseActive participationTreatment OutcomechemistryIndansPhysical therapyFemaleCholinesterase InhibitorsGeriatrics and GerontologyTraining programPsychologyGerontologymedicine.drugArchives of gerontology and geriatrics
researchProduct

Honeybees produce millimolar concentrations of non-neuronal acetylcholine for breeding: possible adverse effects of neonicotinoids

2016

The worldwide use of neonicotinoid pesticides has caused concern on account of their involvement in the decline of bee populations, which are key pollinators in most ecosystems. Here we describe a role of non-neuronal acetylcholine (ACh) for breeding of Apis mellifera carnica and a so far unknown effect of neonicotinoids on non-target insects. Royal jelly or larval food are produced by the hypopharyngeal gland of nursing bees and contain unusually high ACh concentrations (4–8 mM). ACh is extremely well conserved in royal jelly or brood food because of the acidic pH of 4.0. This condition protects ACh from degradation thus ensuring delivery of intact ACh to larvae. Raising the pH to ≥5.5 and…

MaleB Vitamins0301 basic medicineInsecticideslcsh:MedicineToxicologychemistry.chemical_compoundLarvae0302 clinical medicineRoyal jellyMedicine and Health SciencesPollinationlcsh:ScienceNeuronsLiquid ChromatographyLarvaMultidisciplinarybiologyOrganic CompoundsReproductionChromatographic TechniquesVitaminsBeesNitro CompoundsThiaclopridInsectsChemistryLarvaPhysical SciencesFemaleHoney BeesMuscle ContractionResearch Articlefood.ingredientArthropodaGuinea PigsCholinesResearch and Analysis MethodsAnabasineCholine O-Acetyltransferase03 medical and health sciencesfoodAdverse Reactionsddc:570Animalsddc:610Immunohistochemistry TechniquesNutritionCholinesterasePharmacologyMetamorphosisOrganic Chemistrylcsh:RfungiOrganismsChemical CompoundsNeonicotinoidBiology and Life SciencesClothianidinMuscle SmoothPesticideInvertebratesHymenopteraAcetylcholineHigh Performance Liquid ChromatographyBroodDietHistochemistry and Cytochemistry TechniquesHypopharynx030104 developmental biologychemistryImmunologic Techniquesbiology.proteinlcsh:Q030217 neurology & neurosurgeryDevelopmental Biology
researchProduct

Acetylcholine overflow from isolated perfused hearts of various species in the absence of cholinesterase inhibition

1977

1. The content of acetylcholine in the tissue and effluent of isolated hearts of various birds and mammals was determined in the absence of inhibition of cholinesterase. 2. Stimulation of both vagus nerves for 15 min at 20 Hz caused marked negative chronotropic effects in all species. Spontaneous or stimulation-induced overflow of acetylcholine into the effluents was not detected in mammals. In the avian heart, the order of spontaneous overflow was: duck = chicken > pigeon, whereas the order of evoked overflow was: chicken > pigeon > duck. The acetylcholine overflow from the cat heart was below the limit of estimation (3 pmol g−1 min−1). In the chicken heart, the evoked overflow per min (28…

MaleChronotropicmedicine.medical_specialtyPhysostigmineanimal structuresAcetylcholine synthesisPhysostigmineGuinea PigsStimulationIn Vitro TechniquesBiologyBirdsParasympathetic nervous systemSpecies SpecificityInternal medicinemedicineAnimalsColumbidaeCholinesteraseMammalsPharmacologyMyocardiumVagus NerveGeneral MedicineAcetylcholineElectric StimulationCholinesterase inhibitionDucksEndocrinologymedicine.anatomical_structurenervous systemCatscardiovascular systembiology.proteinFemaleCholinesterase InhibitorsRabbitsChickensAcetylcholinemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Mildronate enhances learning/memory and changes hippocampal protein expression in trained rats.

2013

Previously we demonstrated that mildronate [3-(2,2,2-trimethylhydrazinium) propionate dihydrate], a representative of the aza-butyrobetaine class of compounds, protects mitochondrial metabolism under conditions such as ischemia. Mildronate also acted as a neuroprotective agent in an azidothymidine-induced mouse model of neurotoxicity, as well as in a rat model of Parkinson's disease. These observations suggest that mildronate may stimulate processes involved in cell survival and change expression of proteins involved in neurogenic processes. The present study investigated the influence of mildronate on learning and memory in the passive avoidance response (PAR) test and the active condition…

MaleClinical BiochemistryGlutamate decarboxylaseBlotting WesternNerve Tissue ProteinsPharmacologyHippocampal formationToxicologyBiochemistryNeuroprotectionHippocampusBehavioral Neurosciencechemistry.chemical_compoundMemorymedicineAnimalsLearningRats WistarBiological PsychiatryPharmacologyChemistryGlutamate DecarboxylaseNeurotoxicitymedicine.diseaseAcetylcholinesteraseNeural stem cellRatsBromodeoxyuridineAcetylcholinesteraseCholinergicNeuroscienceBromodeoxyuridineMethylhydrazinesPharmacology, biochemistry, and behavior
researchProduct

Release of [3H]acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation

1986

Two different preparations of the rat phrenic nerve-hemidiaphragm (whole nerve-muscle preparation, end-plate preparation) were used for studying synthesis and release of radioactive acetylcholine in the absence and presence of cholinesterase inhibitors. When the whole nerve-muscle preparation (110-180 mg) was incubated with [3H]choline, only small amounts of radioactive acetylcholine were synthesized within the tissue. Electrical nerve stimulation of the whole nerve-muscle preparation produced no increase in tritium outflow. Incubation of the end-plate preparation (16-29 mg) which was obtained after removal of most of the muscle mass led to the formation of large amounts of [3H]acetylcholin…

MaleDiaphragmNeuromuscular JunctionStimulationIn Vitro TechniquesNeuromuscular junctionCholinechemistry.chemical_compoundmedicineAnimalsCholinePhrenic nerveCholinesterasePharmacologyNeurotransmitter AgentsbiologyRats Inbred StrainsHemicholinium 3General MedicineAcetylcholineMuscle DenervationRatsPhrenic Nervemedicine.anatomical_structurechemistryAnesthesiaTetrodotoxinbiology.proteinBiophysicsLiberationAcetylcholinemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

alpha-Bungarotoxin, kappa-bungarotoxin, alpha-cobratoxin and erabutoxin-b do not affect [3H]acetylcholine release from the rat isolated left hemidiap…

1995

Endplate preparations of the rat left hemidiaphragm were incubated with [3H]choline to label neuronal transmitter stores. Nerve evoked release of newly-synthesized [3H]acetylcholine was measured in the absence of cholinesterase inhibitors to investigate whether snake venom neurotoxins by blocking presynaptic nicotinic autoreceptors affect evoked transmitter release. Contractions of the indirectly stimulated hemidiaphragm were recorded to characterize the blocking effect of alpha-neurotoxins at the post-synaptic nicotinic receptors. Neither the long chain neurotoxins alpha-cobratoxin (1 microgram ml-1) and alpha-bungarotoxin (5 microgram ml-1) nor the short chain neurotoxin erabutoxin-b (0.1…

MaleDiaphragmNeurotoxinsPharmacologyReceptors NicotinicTritiumSynaptic TransmissionPostsynaptic potentialmedicineAnimalsCobra Neurotoxin ProteinsChromatography High Pressure LiquidCholinesterasePharmacologyErabutoxinsbiologyChemistryMuscle SmoothGeneral MedicineBungarotoxinmusculoskeletal systemBungarotoxinsAcetylcholineRatsPhrenic NerveNicotinic agonistSnake venomIsotope Labelingbiology.proteinAutoreceptorFemaleCobratoxinNeuroscienceAcetylcholinemedicine.drugMuscle ContractionSnake VenomsNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Effect of controlled-release delivery on the pharmacokinetics of oxybutynin at different dosages: severity-dependent treatment of the overactive blad…

2004

OBJECTIVE To assess the pharmacokinetics of a controlled-release formulation of oxybutynin (OROS®-O, ALZA Corp., Mountain View, CA) at different dosages, compared with immediate-release oxybutynin (IR-O), and to determine the pharmacodynamic properties in the severity-dependent reduction of urge urinary incontinence (UUI). PATIENTS AND METHODS In all, 105 patients were enrolled in this multicentre, randomized, double-blind study. Individual dose titration was used to assess the minimum effective, maximum tolerated or maximum allowed dose of either OROS-O or IR-O. Blood samples were collected during maintenance therapy with frequent sampling to analyse for R-oxybutynin and R-desethyloxybutyn…

MaleDoseUrologyUrinary incontinenceDouble-Blind MethodPharmacokineticsMaintenance therapymedicineHumansDosingOxybutyninDose-Response Relationship Drugbusiness.industryMiddle Agedmedicine.diseaseUrinary IncontinenceOveractive bladderDelayed-Action PreparationsAnesthesiaPharmacodynamicsMandelic AcidsFemaleCholinesterase Inhibitorsmedicine.symptombusinessmedicine.drugBJU International
researchProduct

Therapeutic Drug Monitoring for Patients With Alzheimer Dementia to Improve Treatment With Donepezil

2015

BACKGROUND Aiming to verify that therapeutic drug monitoring has the potential to optimize treatment with acetylcholine esterase inhibitors of patients with Alzheimer dementia, this study investigated whether serum concentrations of donepezil are associated with clinical improvement. METHODS Clinical improvement was measured using the clinical global impression (CGI) scale, and donepezil concentrations were measured in serum by a high-performance liquid chromatographic method with spectrophotometric detection. RESULTS In total, 206 serum samples from 106 patients (49.5% female) were retrospectively available for analysis. Patients included were treated under everyday conditions. Their mean …

MaleDrugmedicine.medical_specialtymedia_common.quotation_subjectGastroenterologyPiperidinesAlzheimer DiseaseInternal medicinemental disordersmedicineHumansDonepezilPharmacology (medical)DonepezilAgedRetrospective Studiesmedia_commonPharmacologyDose-Response Relationship DrugReceiver operating characteristicmedicine.diagnostic_testbusiness.industryRetrospective cohort studyAlzheimer dementiaDose–response relationshipTreatment OutcomeTherapeutic drug monitoringIndansClinical Global ImpressionFemaleCholinesterase InhibitorsDrug Monitoringbusinessmedicine.drugTherapeutic Drug Monitoring
researchProduct

Effect of cholinergic stimulation in early Alzheimer's disease - functional imaging during a recognition memory task.

2011

Treatment of Alzheimer's disease (AD) with acetylcholinesterase inhibitors (AChEI) enhances cholinergic activity and alleviates clinical symptoms. In the present functional magnetic resonance imaging (fMRI) study, we investigated the effect of the AChEI rivastigmine on cognitive function and brain activation patterns during a face recognition memory task. Twenty patients with newly-diagnosed mild AD were administered a single oral dose of placebo, a single dose of rivastigmine (acute), and twice-daily treatment with rivastigmine for 4 weeks (chronic). After each treatment, the patients underwent a facial recognition task during fMRI. The prefrontal areas known to be involved in face recogni…

MalePhenylcarbamatesRivastigmineBrain mappingDouble-Blind MethodAlzheimer DiseaseMemorymedicineImage Processing Computer-AssistedHumansPrefrontal cortexCognitive reserveRecognition memoryAgedRivastigmineBrain Mappingmedicine.diagnostic_testWorking memoryCognitionMagnetic Resonance ImagingNeurologyPattern Recognition VisualFemaleNeurology (clinical)Cholinesterase InhibitorsFunctional magnetic resonance imagingPsychologyNeurosciencemedicine.drugCurrent Alzheimer research
researchProduct

The effects of phorbol esters on choline phospholipid hydrolysis in heart and brain

1990

The efflux of choline was determined in rat striatal slices, incubated chicken atria and perfused chicken hearts. 4 beta-Phorbol-12 beta,13 alpha-dibutyrate (PDB) and 4 beta-phorbol-12 beta-myristate, 13 alpha-acetate (PMA) were used to stimulate protein kinase C. The other phorbol esters, 4 beta-phorbol-13 alpha-acetate (PAc) and 4 alpha-phorbol-12 beta,13 alpha-didecanoate (4 alpha PDD), known to be inactive, were tested to evaluate the specificity of the responses. PDB markedly enhanced the efflux of choline in all of the three preparations. The PDB-evoked efflux of choline in incubated chicken atria was equal to the net production of choline and, therefore, was not caused by translocati…

MalePhospholipidIn Vitro TechniquesBiologychemistry.chemical_compoundPhosphatidylcholinePhorbol EstersmedicineAnimalsCholinePhorbol 1213-DibutyrateProtein kinase CCholinesteraseBrain ChemistryPharmacologyHydrolysisMyocardiumHeartRats Inbred StrainsRatsEGTAchemistryBiochemistryPhosphatidylcholinesbiology.proteinTetradecanoylphorbol AcetateEffluxChickensAcetylcholinemedicine.drugEuropean Journal of Pharmacology: Molecular Pharmacology
researchProduct